Aldeyra Therapeutics Ownership | Who Owns Aldeyra Therapeutics?

Overview Forecast RevenueFinancials Chart

Aldeyra Therapeutics Ownership Summary

Aldeyra Therapeutics is owned by 59.16% institutional investors, 2.44% insiders, and 38.40% retail investors. Perceptive advisors is the largest institutional shareholder, holding 15.61% of ALDX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.96% of its assets in Aldeyra Therapeutics shares.

ALDX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Aldeyra Therapeutics	59.16%	2.44%	38.40%
Sector	Healthcare Stocks	47.38%	7.99%	44.63%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Perceptive advisors	9.28M	15.61%	$30.70M
Knoll capital management	5.48M	9.22%	$18.12M
Vanguard group	3.74M	6.30%	$12.39M
Blackrock	3.62M	6.10%	$11.99M
Kennedy capital management	1.60M	2.69%	$5.29M
Geode capital management	1.14M	1.92%	$3.77M
State street	957.72K	1.61%	$3.17M
Eagle asset management	841.57K	1.42%	$2.74M
Dimensional fund advisors lp	672.06K	1.13%	$2.22M
Federated hermes	531.22K	0.89%	$1.76M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Knoll capital management	5.48M	12.21%	$18.12M
Perceptive advisors	9.28M	0.73%	$30.70M
Kennedy capital management	1.60M	0.11%	$5.29M
Pfg investments	396.25K	0.09%	$1.31M
Palo alto investors lp	225.47K	0.09%	$746.29K
Providence wealth advisors	25.00K	0.07%	$84.00K
Joseph p. lucia & associates	28.25K	0.05%	$93.51K
Laidlaw wealth management	16.88K	0.03%	$55.86K
International assets investment management	57.80K	0.02%	$191.32K
Tobias financial advisors	23.70K	0.02%	$78.43K

Top Buyers

Holder	Shares	% Assets	Change
Perceptive advisors	9.28M	0.73%	682.26K
Federated hermes	531.22K	0.00%	531.22K
Pfg investments	396.25K	0.09%	396.25K
Blackrock	3.62M	0.00%	311.16K
Kennedy capital management	1.60M	0.11%	281.52K

Top Sellers

Holder	Shares	% Assets	Change
Verition fund management	219.83K	0.00%	-720.57K
Millennium management	43.83K	0.00%	-344.88K
Johnson & johnson	-	-	-299.67K
D. e. shaw	321.94K	0.00%	-225.70K
Renaissance	503.30K	0.00%	-224.39K

New Positions

Holder	Shares	% Assets	Change	Value
Pfg investments	396.25K	0.09%	396.25K	$1.31M
Panagora asset management	60.30K	0.00%	60.30K	$199.59K
Cibc private wealth group	51.46K	0.00%	51.46K	$170.33K
Alps advisors	46.33K	0.00%	46.33K	$153.34K
Corebridge financial	26.80K	0.00%	26.80K	$88.72K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-9.00
Innealta capital	-46.00
Metropolitan life insurance co/ny	-197.00
Truvestments capital	-265.00
Lindbrook capital	-544.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	105	-0.94%	35,151,111	-0.76%	59	1.64%	51	10.87%	31	-6.06%
Mar 31, 2024	106	-2.75%	35,421,654	0.85%	60	1.70%	46	-	33	-28.26%
Dec 31, 2023	109	-13.49%	35,123,488	-7.02%	59	1.44%	46	-13.21%	46	15.00%
Sep 30, 2023	126	-4.55%	37,775,100	-3.23%	64	1.46%	53	-28.38%	40	42.86%
Jun 30, 2023	132	11.86%	39,037,783	9.70%	66	1.81%	74	25.42%	28	7.69%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.76M	2.96%	-
iShares Russell 2000 ETF	1.30M	2.18%	-2.91K
Kennedy Micro Cap	859.51K	1.45%	-273.37K
Vanguard Institutional Extnd Mkt Idx Tr	697.57K	1.17%	-37.47K
Vanguard Explorer Inv	680.00K	1.14%	-
Invesco Dorsey Wright SmallCap Momt ETF	634.12K	1.07%	-
Fidelity Small Cap Index	510.13K	0.86%	-9.97K
iShares Russell 2000 Value ETF	415.31K	0.70%	-
Eagle Small Cap Growth – Institutional	376.02K	0.63%	-83.48K
State St Russell Sm/Mid Cp® Indx NL Cl C	325.10K	0.55%	-10.20K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 03, 2021	Miller-Rich Nancy	-	Buy	$5.29K
Apr 12, 2023	Miller-Rich Nancy	-	Buy	$5.16K
Aug 12, 2024	Machatha Stephen	Chief Development Officer	Sell	$75.97K
Aug 12, 2024	Greenberg Bruce	See Remarks	Sell	$51.31K
Mar 12, 2024	Machatha Stephen	Chief Development Officer	Sell	$36.50K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	2
2024 Q2	5	-
2024 Q1	-	7
2023 Q4	-	2
2023 Q3	-	-

ALDX Ownership FAQ

Who Owns Aldeyra Therapeutics?

Aldeyra Therapeutics shareholders are primarily institutional investors at 59.16%, followed by 2.44% insiders and 38.40% retail investors. The average institutional ownership in Aldeyra Therapeutics's industry, Biotech Stocks , is 45.43%, which Aldeyra Therapeutics exceeds.

Who owns the most shares of Aldeyra Therapeutics?

Aldeyra Therapeutics’s largest shareholders are Perceptive advisors (9.28M shares, 15.61%), Knoll capital management (5.48M shares, 9.22%), and Vanguard group (3.74M shares, 6.30%). Together, they hold 31.13% of Aldeyra Therapeutics’s total shares outstanding.

Does Blackrock own Aldeyra Therapeutics?

Yes, BlackRock owns 6.10% of Aldeyra Therapeutics, totaling 3.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.99M$. In the last quarter, BlackRock increased its holdings by 311.16K shares, a 9.40% change.

Who is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested?

Knoll capital management is Aldeyra Therapeutics’s biggest shareholder by percentage of total assets invested, with 12.21% of its assets in 5.48M Aldeyra Therapeutics shares, valued at 18.12M$.

Who is the top mutual fund holder of Aldeyra Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aldeyra Therapeutics shares, with 2.96% of its total shares outstanding invested in 1.76M Aldeyra Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools